Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAFIK ABADIER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1649253147
CMS profile
256213
Location
INVERNESS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$285.07

11 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $285.07 11

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAFIK ABADIER

NPI 1649253147 · CMS profile ID 256213

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

INVERNESS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649253147?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAFIK ABADIER, NPI 1649253147, CMS profile ID 256213. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649253147?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). RAFIK ABADIER, NPI 1649253147, CMS profile ID 256213. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649253147?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
RAFIK ABADIER, NPI 1649253147, CMS profile ID 256213, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1649253147?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

11 matching records · $285.07 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 11 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–11 of 11.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $16.1008/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719360891 CMS
Philips Electronics North America Corporation $12.7608/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751362613 CMS
BIOTRONIK INC. $17.0007/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751876301 CMS
BIOTRONIK INC. $15.5006/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751876289 CMS
Boston Scientific Corporation $90.7406/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725493551 CMS
BIOTRONIK INC. $12.8602/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751876249 CMS
Janssen Pharmaceuticals, Inc $17.6302/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719360889 CMS
PFIZER INC. $16.6402/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743130769 CMS
Boston Scientific Corporation $21.1801/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725493545 CMS
Boston Scientific Corporation $45.6601/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725493541 CMS
Amgen Inc. $19.0001/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741430659 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,012.13 30
PY2020 $285.07 11
PY2021 $127.23 4
PY2022 $153.51 10
PY2023 $3,321.33 24
PY2024 $2,191.02 22
PY2025 $222.26 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $731.79 4
PY2025 Principal investigator $554,369.24 96
PY2024 Principal investigator $1,358,878.08 258
PY2023 Principal investigator $1,095,651.17 1,020
PY2022 Principal investigator $767,493.58 1,505
PY2021 Principal investigator $331,251.89 220
PY2020 Principal investigator $152,753.28 147
PY2019 Principal investigator $85,046.12 52

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

52 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $849.00 12/13/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926925
Principal investigator 1 Boehringer Ingelheim International GmbH $849.00 12/13/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928035
Principal investigator 1 Boehringer Ingelheim International GmbH $849.00 12/13/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928037
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923291
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923759
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923769
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923771
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923849
Principal investigator 1 Boehringer Ingelheim International GmbH $1,096.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923857
Principal investigator 1 Boehringer Ingelheim International GmbH $920.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924017
Principal investigator 1 Boehringer Ingelheim International GmbH $1,310.00 11/22/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924327
Principal investigator 1 Boehringer Ingelheim International GmbH $103.52 11/04/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928485
Principal investigator 1 Boehringer Ingelheim International GmbH $818.00 11/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703923845
Principal investigator 1 Boehringer Ingelheim International GmbH $60.81 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926899
Principal investigator 1 Boehringer Ingelheim International GmbH $121.63 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927569
Principal investigator 1 Boehringer Ingelheim International GmbH $60.81 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927571
Principal investigator 1 Boehringer Ingelheim International GmbH $30.41 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927573
Principal investigator 1 Boehringer Ingelheim International GmbH $60.81 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927649
Principal investigator 1 Boehringer Ingelheim International GmbH $60.81 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927651
Principal investigator 1 Boehringer Ingelheim International GmbH $4.37 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927653
Principal investigator 1 Boehringer Ingelheim International GmbH $60.81 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927655
Principal investigator 1 Boehringer Ingelheim International GmbH $81.09 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928247
Principal investigator 1 Boehringer Ingelheim International GmbH $51.00 10/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928343
Principal investigator 1 Boehringer Ingelheim International GmbH $1,102.00 09/05/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918757
Principal investigator 1 Boehringer Ingelheim International GmbH $397.00 09/05/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918759
Principal investigator 1 Amarin Pharma Inc. $12,030.00 08/08/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH, LLC
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio No dispute reported 06/30/2026 700952557
Principal investigator 1 Boehringer Ingelheim International GmbH $10.27 08/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703919059
Principal investigator 1 Boehringer Ingelheim International GmbH $10.27 08/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920589
Principal investigator 1 Boehringer Ingelheim International GmbH $13.17 08/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920591
Principal investigator 1 Boehringer Ingelheim International GmbH $10.27 08/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920593
Principal investigator 1 Boehringer Ingelheim International GmbH $10.27 08/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703925967
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $5,082.89 07/31/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704729767
Principal investigator 1 Boehringer Ingelheim International GmbH $116.00 06/12/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913129
Principal investigator 1 Boehringer Ingelheim International GmbH $20.79 05/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913801
Principal investigator 1 Boehringer Ingelheim International GmbH $10.39 04/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914457
Principal investigator 1 Boehringer Ingelheim International GmbH $10.39 04/02/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914525
Principal investigator 1 Novartis Pharmaceuticals Corporation $33,654.85 03/18/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH
A MULTICENTER RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFECTS OF LCZ696 COMPARED TO VALSARTAN ON COGNITIVE FUNCTION AS ASSESSED BY COMPREHENSIVE NEUROCOGNITIVE BATTERY AND BRAIN AMYLOID PLAQUE DEPOSITION AS ASSESSED BY PET IMAGING No dispute reported 06/30/2026 640721649
Principal investigator 1 Amgen Inc. $2,763.91 03/08/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH
GALACTIC-HF No dispute reported 06/30/2026 675788345
Principal investigator 1 Boehringer Ingelheim International GmbH $135.43 03/04/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910481
Principal investigator 1 Boehringer Ingelheim International GmbH $931.00 03/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910479
Principal investigator 1 Amgen Inc. $690.00 02/19/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH
GALACTIC-HF No dispute reported 06/30/2026 675788347
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703906989
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703906991
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910467
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910469
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910471
Principal investigator 1 Boehringer Ingelheim International GmbH $10.61 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910473
Principal investigator 1 Boehringer Ingelheim International GmbH $40.83 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910475
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910477
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
Nature Coast Clinical Research
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926493
Principal investigator 1 Amgen Inc. $77.25 01/01/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH
GALACTIC-HF No dispute reported 06/30/2026 675788349
Principal investigator 1 Novartis Pharmaceuticals Corporation $14,902.92 01/01/2019 Non-covered Recipient Entity
NATURE COAST CLINICAL RESEARCH
PROSPECTIVE COMPARISON OF COMBINED ANGIOTENSIN NEPRILYSIN INHIBITION WITH LCZ696 RELATIVE TO ENALAPRIL ON CENTRAL AORTIC STIFFNESS AND VENTRICULAR VASCULAR COUPLING IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION No dispute reported 06/30/2026 640721655